We are now valued at $100 million less than our cash on hand. I think there is flight from the health stock sector because of uncertainty in the market after the incoming president chose a vaccine hater and conspiracy lover to be in charge of the nation's health. It has definitely given a fever to health care stocks. As for Amarin, I'm sure some investors who were counting on a sale are bailing. If the company did anything during it's Investor Day, otherwise known as Drive-Down-This-Stock Day, it made it clear that its comeback plan is a slow one, relying on the trickle in overseas sales someday growing to a flood. For those who don't want to wait another three to five years, they pressed the sell button. I'm not critical of Amarin though. I think they've done an incredible job of preserving cash over the past two years while income keeps dropping 50 percent a year. I think the company meant to signal that the worst of times are over and that overseas sales will now become a steadily larger piece of the income pie each quarter. But the message heard by too many investors was: No sale of the company in the next three years.
Market Data 
Markets 
AI
